Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 1998

View Archived Issues

Sankyo describes NK1/NK2 antagonists for treating asthma

Japanese lab describes new agents for asthma and inflammation

Deferiprone increases incidence of hepatic fibrosis and fails to control iron in thalassemia major

Eptifibatide treatment reduces incidence of death in acute myocardial infarction and unstable angina

Efficacy of collagen membrane delivery systems for rhBMP-2 in treatment of periodontal defects

Laboratory testing of new, more efficient Toleragen drug completed

First diagnostic kit for the detection of stroke developed by Skye PharmaTech

Elan and Endorex form new company to develop oral vaccines

Viagra and nitrates: a lethal combination

Anergen claims production methods for AnergiX compounds

Pfizer selects LTB4 antagonist for clinical testing

New agents for pancreatitis in early development at Sankyo

More asiatic acid derivatives in development at Dong Kook

Bristol-Myers Squibb discovers novel maxi-K channel openers

Toray reports kappa agonists for treating dermatological disorders

HERS study results now in -- results counter expectations

Disappointing results obtained in phase II/III trial of LU-25-109T

Onconase inhibits cancer cell growth and contributes to apoptosis

Il Yang synthesizes gastric H+/K+-ATPase inhibitors with improved stability

First approval for lamivudine in chronic hepatitis B

Nymox progresses with development of NX-B4221

FDA advisory committee meeting scheduled to review Enbrel BLA

Antiasthma drug candidate enters phase I testing at Pharmacia & Upjohn

Lilly describes promising beta3-adrenoceptor agonist at ACS meeting

ACS news flash: R.W. Johnson investigates thrombin inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...